Science 37

Last updated: January 16, 2024

David Coman, CEO
David Coman, CEO
Country: USA | Funding: $347.5M (+)

Website: http://science37.com/

Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models.